## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.6% in lower entry zone (3.0-6.0%), top quartile (76th pct) cross-sectional ranking. Short-term MRS_5 (1.5%) confirms momentum alignment. Outperforming sector by 2.5%. Caution: momentum weakening (-3.1% MRS), overbought RSI (71).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($446.14)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Synopsys targets $9.61B revenue for 2026 while advancing joint AI solutions and accelerating Ansys integration**
- Source: MSN | 20251211T015325 | Bullish | Relevance: 99%
- This article mentions that Synopsys is targeting a revenue of $9.61 billion for 2026. This financial goal is coupled with the company's efforts to advance joint AI solutions and expedite the integration of Ansys.

**2. Investors SueWallSt as Synopsys, Inc. Faces Securities Fraud Allegations**
- Source: WJBF | 20251209T220919 | Neutral | Relevance: 99%
-  A class action lawsuit has been filed against Synopsys, Inc. on behalf of investors who reportedly lost money due to alleged securities fraud between December 4, 2024, and September 9, 2025. Levi & Korsinsky, LLP, which specializes in complex securities litigation, is representing the investors. Those affected are encouraged to contact Levi & Korsinsky for more information.

**3. Synopsys Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts**
- Source: Benzinga | 20251210T070923 | Somewhat-Bullish | Relevance: 99%
-  Synopsys, Inc. (NASDAQ: SNPS) is preparing to release its Q4 earnings, with analysts expecting $2.88 earnings per share on $2.24 billion in revenue. The company recently expanded its partnership with NVIDIA (NASDAQ: NVDA). Several prominent analysts have updated their ratings and price targets for Synopsys ahead of the earnings call.

**4. Investors SueWallSt as Synopsys, Inc. Faces Securities Fraud Allegations**
- Source: PIX11 | 20251209T220851 | Neutral | Relevance: 99%
-  A class-action lawsuit has been filed against Synopsys, Inc. on behalf of investors who allege securities fraud occurred between December 4, 2024, and September 9, 2025. Investors who suffered losses are encouraged to contact Levi & Korsinsky for more information about joining the lawsuit. Levi & Korsinsky, a firm specializing in securities litigation, is actively representing aggrieved shareholders in this case.

**5. Investors SueWallSt as Synopsys, Inc. Faces Securities Fraud Allegations**
- Source: Fox 59 | 20251209T220852 | Neutral | Relevance: 99%
- A class action lawsuit has been filed against Synopsys, Inc. on behalf of investors who allegedly suffered financial losses due to securities fraud between December 4, 2024, and September 9, 2025. Levi & Korsinsky, LLP, which specializes in complex securities litigation, is representing the aggrieved shareholders and encourages affected investors to come forward.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | JP Morgan | $650 | $600 | +8% |
| 2025-12-11 | Wells Fargo | $500 | $445 | +12% |
| 2025-12-11 | Keybanc | $600 | $575 | +4% |
| 2025-12-11 | B of A Securiti | $560 | $500 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | JP Morgan | main | Overweight |
| 2025-12-11 | Wells Fargo | main | Equal-Weight |
| 2025-12-11 | Keybanc | main | Overweight |
| 2025-12-11 | B of A Securiti | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.54M) |
| Sells | 3 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. High beta (2.10) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Valuation stretched: PEG 6.1x requires aggressive growth execution.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Analyst target momentum: 5 raises (avg +8%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 6.11 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 31%). Revenue growth strong at 37% YoY. Insider buying signal ($0.5M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $91.0B |
| Beta | 1.00 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.11 |
| Forward P/E | 27.6 |
| Current P/E | 33.2 |
| YoY Growth | 20.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 6.7% to 3.6% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 76th percentile. MRS_5 at 1.5% confirms short-term momentum alignment. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (8.47), confirming momentum. RSI overbought at 71, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.62% (CS: 76) | Strong |
| RSI_14 | 70.8 | Overbought |
| MACD Histogram | 8.47 | Bullish |
| vs SMA20 | 1.120x | Above |
| vs SMA50 | 1.091x | Above |
| vs SMA200 | 0.977x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $477.26
- **Stop Loss:** $446.14 (6.5% risk)
- **Target:** $523.94 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 44
- **Position Value:** $20,999.44
- **Portfolio %:** 21.00%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |
| 2024Q4 | $3.30 | $3.40 | +3.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*